| ACH-GABAPENTIN (600 MG) | 02392526 | Marketed | Accord Healthcare Inc | Nov 2025 |
| ACH-GABAPENTIN (100 MG) | 02416840 | Marketed | Accord Healthcare Inc | Nov 2025 |
| ACH-GABAPENTIN (300 MG) | 02416859 | Marketed | Accord Healthcare Inc | Nov 2025 |
| ACH-GABAPENTIN (400 MG) | 02416867 | Marketed | Accord Healthcare Inc | Nov 2025 |
| APO-GABAPENTIN (100 MG) | 02244304 | Marketed | Apotex Inc. | Aug 2001 |
| APO-GABAPENTIN (300 MG) | 02244305 | Marketed | Apotex Inc. | Aug 2001 |
| APO-GABAPENTIN (400 MG) | 02244306 | Marketed | Apotex Inc. | Aug 2001 |
| APO-GABAPENTIN (600 MG) | 02293358 | Marketed | Apotex Inc. | Jul 2020 |
| APO-GABAPENTIN (800 MG) | 02293366 | Marketed | Apotex Inc. | Aug 2020 |
| AURO-GABAPENTIN (100 MG) | 02321203 | Marketed | Auro Pharma Inc. | Jun 2011 |
| AURO-GABAPENTIN (300 MG) | 02321211 | Marketed | Auro Pharma Inc. | Jun 2011 |
| AURO-GABAPENTIN (400 MG) | 02321238 | Marketed | Auro Pharma Inc. | Jun 2011 |
| AURO-GABAPENTIN TABLETS (600 MG) | 02428334 | Marketed | Auro Pharma Inc. | Jan 2019 |
| AURO-GABAPENTIN TABLETS (800 MG) | 02428342 | Marketed | Auro Pharma Inc. | Jan 2019 |
| GABAPENTIN (100 MG) | 02246314 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| GABAPENTIN (300 MG) | 02246315 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| GABAPENTIN (400 MG) | 02246316 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| GABAPENTIN (100 MG) | 02353245 | Marketed | Sanis Health Inc. | Oct 2013 |
| GABAPENTIN (300 MG) | 02353253 | Marketed | Sanis Health Inc. | Oct 2013 |
| GABAPENTIN (400 MG) | 02353261 | Marketed | Sanis Health Inc. | Oct 2013 |
| GABAPENTIN (600 MG) | 02388200 | Marketed | Sivem Pharmaceuticals Ulc | May 2019 |
| GABAPENTIN (800 MG) | 02388219 | Marketed | Sivem Pharmaceuticals Ulc | Mar 2019 |
| GABAPENTIN (600 MG) | 02431289 | Marketed | Sanis Health Inc. | Aug 2020 |
| GABAPENTIN (600 MG) | 02432072 | Marketed | JAMP Pharma Corporation | May 2023 |
| GABAPENTIN (800 MG) | 02432080 | Marketed | JAMP Pharma Corporation | May 2023 |
| GLN-GABAPENTIN (600 MG) | 02410990 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Sep 2019 |
| GLN-GABAPENTIN (800 MG) | 02411008 | Marketed | Glenmark Pharmaceuticals Canada Inc. | May 2019 |
| JAMP GABAPENTIN CAPSULES (100 MG) | 02535246 | Marketed | JAMP Pharma Corporation | Mar 2024 |
| JAMP GABAPENTIN CAPSULES (300 MG) | 02535254 | Marketed | JAMP Pharma Corporation | Mar 2024 |
| JAMP GABAPENTIN CAPSULES (400 MG) | 02535262 | Marketed | JAMP Pharma Corporation | Mar 2024 |
| MINT-GABAPENTIN (100 MG) | 02408880 | Marketed | Mint Pharmaceuticals Inc | Aug 2023 |
| MINT-GABAPENTIN (300 MG) | 02408899 | Marketed | Mint Pharmaceuticals Inc | Aug 2023 |
| MINT-GABAPENTIN (400 MG) | 02408902 | Marketed | Mint Pharmaceuticals Inc | Aug 2023 |
| NEURONTIN (100 MG) | 02084260 | Marketed | BGP Pharma ULC | May 2023 |
| NEURONTIN (300 MG) | 02084279 | Marketed | BGP Pharma ULC | May 2023 |
| NEURONTIN (400 MG) | 02084287 | Marketed | BGP Pharma ULC | May 2023 |
| NEURONTIN (600 MG) | 02239717 | Marketed | BGP Pharma ULC | May 2023 |
| NEURONTIN (800 MG) | 02239718 | Marketed | BGP Pharma ULC | May 2023 |
| NRA-GABAPENTIN (100 MG) | 02550016 | Marketed | Nora Pharma Inc. | Jun 2025 |
| NRA-GABAPENTIN (300 MG) | 02550024 | Marketed | Nora Pharma Inc. | Jun 2025 |
| NRA-GABAPENTIN (400 MG) | 02550032 | Marketed | Nora Pharma Inc. | Jun 2025 |
| PMS-GABAPENTIN (100 MG) | 02243446 | Marketed | Pharmascience Inc. | Feb 2001 |
| PMS-GABAPENTIN (300 MG) | 02243447 | Marketed | Pharmascience Inc. | Feb 2001 |
| PMS-GABAPENTIN (400 MG) | 02243448 | Marketed | Pharmascience Inc. | Feb 2001 |
| PRO-GABAPENTIN (100 MG) | 02310449 | Marketed | Pro Doc Limitee | Aug 2026 |
| PRO-GABAPENTIN (300 MG) | 02310457 | Marketed | Pro Doc Limitee | Aug 2026 |
| PRO-GABAPENTIN (400 MG) | 02310465 | Marketed | Pro Doc Limitee | Aug 2026 |
| PRO-GABAPENTIN (600 MG) | 02310473 | Marketed | Pro Doc Limitee | Jun 2026 |
| PRO-GABAPENTIN (800 MG) | 02310481 | Marketed | Pro Doc Limitee | Jun 2026 |
| RIVA-GABAPENTIN (100 MG) | 02251167 | Marketed | Laboratoire Riva Inc. | Jan 2026 |
| RIVA-GABAPENTIN (300 MG) | 02251175 | Marketed | Laboratoire Riva Inc. | Jan 2026 |
| RIVA-GABAPENTIN (400 MG) | 02251183 | Marketed | Laboratoire Riva Inc. | Jan 2026 |
| RIVA-GABAPENTIN (600 MG) | 02259796 | Marketed | Laboratoire Riva Inc. | May 2026 |
| RIVA-GABAPENTIN (800 MG) | 02259818 | Marketed | Laboratoire Riva Inc. | May 2026 |
| TEVA-GABAPENTIN (100 MG) | 02244513 | Marketed | Teva Canada Limited | Apr 2010 |
| TEVA-GABAPENTIN (300 MG) | 02244514 | Marketed | Teva Canada Limited | Apr 2010 |
| TEVA-GABAPENTIN (400 MG) | 02244515 | Marketed | Teva Canada Limited | Apr 2010 |
| TEVA-GABAPENTIN (800 MG) | 02247346 | Marketed | Teva Canada Limited | Apr 2010 |
| TEVA-GABAPENTIN (600 MG) | 02248457 | Marketed | Teva Canada Limited | Apr 2010 |
| ACH-GABAPENTIN (800 MG) | 02392534 | Dormant | Accord Healthcare Inc | Sep 2026 |
| AG-GABAPENTIN (100 MG) | 02477912 | Dormant | Angita Pharma Inc. | Jul 2024 |
| AG-GABAPENTIN (300 MG) | 02477920 | Dormant | Angita Pharma Inc. | Jul 2024 |
| AG-GABAPENTIN (400 MG) | 02477939 | Dormant | Angita Pharma Inc. | Jul 2024 |
| APO-GABAPENTIN TABLETS (600 MG) | 02519771 | Approved | Apotex Inc. | Sep 2021 |
| APO-GABAPENTIN TABLETS (800 MG) | 02519798 | Approved | Apotex Inc. | Sep 2021 |
| GABAPENTIN (800 MG) | 02403757 | Approved | Apotex Inc. | Mar 2013 |
| GABAPENTIN (600 MG) | 02403765 | Approved | Apotex Inc. | Mar 2013 |
| GABAPENTIN (300 MG) | 02403773 | Approved | Apotex Inc. | Mar 2013 |
| GABAPENTIN (100 MG) | 02403781 | Approved | Apotex Inc. | Mar 2013 |
| GABAPENTIN (400 MG) | 02403803 | Approved | Apotex Inc. | Mar 2013 |
| GABAPENTIN (100 MG) | 02548763 | Approved | Teva Canada Limited | Jun 2024 |
| GABAPENTIN (300 MG) | 02548771 | Approved | Teva Canada Limited | Jun 2024 |
| GABAPENTIN (400 MG) | 02548798 | Approved | Teva Canada Limited | Jun 2024 |
| GABAPENTIN (100 MG) | 02568845 | Approved | Pro Doc Limitee | Jun 2026 |
| GABAPENTIN (300 MG) | 02568853 | Approved | Pro Doc Limitee | Jun 2026 |
| GABAPENTIN (400 MG) | 02568861 | Approved | Pro Doc Limitee | Jun 2026 |
| GABAPENTIN CAPSULES (100 MG) | 02530961 | Approved | Granules India Limited | Sep 2022 |
| GABAPENTIN CAPSULES (300 MG) | 02530988 | Approved | Granules India Limited | Sep 2022 |
| GABAPENTIN CAPSULES (400 MG) | 02530996 | Approved | Granules India Limited | Sep 2022 |
| GABAPENTIN ORAL SOLUTION (250 MG) | 02569868 | Approved | Rubicon Research Canada Limited | Jul 2026 |
| IPG-GABAPENTIN (100 MG) | 02390949 | Approved | Marcan Pharmaceuticals Inc. | Nov 2016 |
| IPG-GABAPENTIN (300 MG) | 02390957 | Approved | Marcan Pharmaceuticals Inc. | Nov 2016 |
| IPG-GABAPENTIN (400 MG) | 02390965 | Approved | Marcan Pharmaceuticals Inc. | Nov 2016 |
| JAMP GABAPENTIN TABLETS (600 MG) | 02402289 | Dormant | JAMP Pharma Corporation | Mar 2026 |
| JAMP GABAPENTIN TABLETS (800 MG) | 02402297 | Dormant | JAMP Pharma Corporation | Mar 2026 |
| PENDO-GABAPENTIN (300 MG) | 02427397 | Approved | Pendopharm Division Of Pharmascience Inc | Aug 2014 |
| ACT GABAPENTIN (100 MG) | 02256142 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT GABAPENTIN (300 MG) | 02256150 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT GABAPENTIN (400 MG) | 02256169 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| BCI GABAPENTIN (300 MG) | 02266768 | Cancelled Pre Market | Baker Cummins Inc | Aug 2017 |
| BIO-GABAPENTIN (100 MG) | 02450143 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| BIO-GABAPENTIN (300 MG) | 02450151 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| BIO-GABAPENTIN (400 MG) | 02450178 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| BIO-GABAPENTIN (600 MG) | 02450186 | Cancelled Post Market | Biomed Pharma | Dec 2021 |
| BIO-GABAPENTIN (800 MG) | 02450194 | Cancelled Post Market | Biomed Pharma | Feb 2022 |
| DOM-GABAPENTIN (100 MG) | 02243743 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-GABAPENTIN (300 MG) | 02243744 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-GABAPENTIN (400 MG) | 02243745 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-GABAPENTIN (600 MG) | 02258153 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-GABAPENTIN (800 MG) | 02258161 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| GABAPENTIN (100 MG) | 02238671 | Cancelled Pre Market | Omni Laboratories Division, Warner-Lambert Canada Inc. | Aug 2017 |
| GABAPENTIN (300 MG) | 02238672 | Cancelled Pre Market | Omni Laboratories Division, Warner-Lambert Canada Inc. | Aug 2017 |
| GABAPENTIN (400 MG) | 02238673 | Cancelled Pre Market | Omni Laboratories Division, Warner-Lambert Canada Inc. | Aug 2017 |
| GABAPENTIN (300 MG) | 02273853 | Cancelled Post Market | Genpharm Inc. | Feb 2009 |
| GABAPENTIN (100 MG) | 02304775 | Cancelled Post Market | Sorres Pharma Inc | Jun 2014 |
| GABAPENTIN (300 MG) | 02304783 | Cancelled Post Market | Sorres Pharma Inc | Jun 2014 |
| GABAPENTIN (400 MG) | 02304791 | Cancelled Post Market | Sorres Pharma Inc | Jun 2014 |
| GABAPENTIN (100 MG) | 02342650 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| GABAPENTIN (300 MG) | 02342669 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| GABAPENTIN (400 MG) | 02342677 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| GABAPENTIN (800 MG) | 02431297 | Cancelled Post Market | Sanis Health Inc. | Mar 2025 |
| GABAPENTIN CAPSULES (100 MG) | 02332582 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2023 |
| GABAPENTIN CAPSULES (300 MG) | 02332590 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2023 |
| GABAPENTIN CAPSULES (400 MG) | 02332604 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2023 |
| GD-GABAPENTIN (100 MG) | 02285819 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Dec 2016 |
| GD-GABAPENTIN (300 MG) | 02285827 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Jan 2018 |
| GD-GABAPENTIN (400 MG) | 02285835 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Jul 2017 |
| GD-GABAPENTIN (600 MG) | 02285843 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Sep 2019 |
| GD-GABAPENTIN (800 MG) | 02285851 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Apr 2017 |
| JAMP-GABAPENTIN (100 MG) | 02361469 | Cancelled Post Market | JAMP Pharma Corporation | May 2026 |
| JAMP-GABAPENTIN (300 MG) | 02361485 | Cancelled Post Market | JAMP Pharma Corporation | May 2026 |
| JAMP-GABAPENTIN (400 MG) | 02361493 | Cancelled Post Market | JAMP Pharma Corporation | May 2026 |
| MAR-GABAPENTIN (100 MG) | 02391473 | Cancelled Post Market | Marcan Pharmaceuticals Inc. | Mar 2026 |
| MAR-GABAPENTIN (300 MG) | 02391481 | Cancelled Post Market | Marcan Pharmaceuticals Inc. | Mar 2026 |
| MAR-GABAPENTIN (400 MG) | 02391503 | Cancelled Post Market | Marcan Pharmaceuticals Inc. | Mar 2026 |
| MAR-GABAPENTIN TABS (600 MG) | 02432706 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Jul 2015 |
| MAR-GABAPENTIN TABS (800 MG) | 02432714 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Jul 2015 |
| MYLAN-GABAPENTIN (100 MG) | 02248259 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Sep 2017 |
| MYLAN-GABAPENTIN (300 MG) | 02248260 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Sep 2017 |
| MYLAN-GABAPENTIN (400 MG) | 02248261 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Dec 2017 |
| MYLAN-GABAPENTIN (600 MG) | 02397471 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Sep 2017 |
| MYLAN-GABAPENTIN (800 MG) | 02397498 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Sep 2017 |
| NTP-GABAPENTIN (600 MG) | 02384973 | Cancelled Pre Market | Teva Canada Limited | Jun 2017 |
| NTP-GABAPENTIN (800 MG) | 02384981 | Cancelled Pre Market | Teva Canada Limited | Jun 2017 |
| NU-GABAPENTIN CAPSULES (100 MG) | 02246742 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-GABAPENTIN CAPSULES (300 MG) | 02246743 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-GABAPENTIN CAPSULES (400 MG) | 02246744 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| PHL-GABAPENTIN (600 MG) | 02258005 | Cancelled Post Market | Pharmel Inc. | Dec 2004 |
| PHL-GABAPENTIN (800 MG) | 02258013 | Cancelled Post Market | Pharmel Inc. | Dec 2004 |
| PMS-GABAPENTIN (600 MG) | 02255898 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| PMS-GABAPENTIN (800 MG) | 02255901 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| PRIVA-GABAPENTIN (100 MG) | 02450097 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-GABAPENTIN (300 MG) | 02450100 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-GABAPENTIN (400 MG) | 02450119 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-GABAPENTIN (600 MG) | 02450127 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-GABAPENTIN (800 MG) | 02450135 | Cancelled Pre Market | Pharmapar Inc. | Jul 2022 |
| RAN-GABAPENTIN (100 MG) | 02319055 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Feb 2023 |
| RAN-GABAPENTIN (300 MG) | 02319063 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Feb 2023 |
| RAN-GABAPENTIN (400 MG) | 02319071 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Feb 2023 |
| RATIO-GABAPENTIN (100 MG) | 02260883 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RATIO-GABAPENTIN (300 MG) | 02260891 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RATIO-GABAPENTIN (400 MG) | 02260905 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RATIO-GABAPENTIN (600 MG) | 02260913 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RATIO-GABAPENTIN (800 MG) | 02260921 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| SIG-GABAPENTIN (100 MG) | 02323575 | Cancelled Pre Market | Sigmacon Lifesciences Inc | Dec 2021 |
| SIG-GABAPENTIN (300 MG) | 02323583 | Cancelled Pre Market | Sigmacon Lifesciences Inc | Dec 2021 |
| SIG-GABAPENTIN (400 MG) | 02323591 | Cancelled Pre Market | Sigmacon Lifesciences Inc | Dec 2021 |
| TARO-GABAPENTIN (100 MG) | 02250888 | Cancelled Pre Market | Taro Pharmaceuticals Inc | Nov 2023 |
| TARO-GABAPENTIN (300 MG) | 02250918 | Cancelled Pre Market | Taro Pharmaceuticals Inc | Nov 2023 |
| TARO-GABAPENTIN (400 MG) | 02250926 | Cancelled Pre Market | Taro Pharmaceuticals Inc | Nov 2023 |
| VAN-GABAPENTIN (100 MG) | 02431408 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-GABAPENTIN (300 MG) | 02431416 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-GABAPENTIN (400 MG) | 02431424 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-GABAPENTIN (600 MG) | 02432544 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-GABAPENTIN (800 MG) | 02432552 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |